The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
D000433:1-Propanol; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001712:Biperiden / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004558:Electric Stimulation; D004576:Electromyography; D008694:Methamphetamine / Q000494:pharmacology; D009046:Motor Neurons / Q000187:drug effects / Q000502:physiology*; D009069:Movement Disorders / Q000139:chemically induced*; D010276:Parasympatholytics / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology; D010830:Physostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine; D013116:Spinal Cord / Q000187:drug effects / Q000502:physiology*; D013127:Spinal Nerves / Q000502:physiology; D013747:Tetrabenazine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000494:pharmacology
D010276:Parasympatholytics; D010880:Piperidines; D001712:Biperiden; D008694:Methamphetamine; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D001285:Atropine; D012110:Reserpine; D000433:1-Propanol; D010830:Physostigmine; D013747:Tetrabenazine